Marium Husain

756 total citations
34 papers, 300 citations indexed

About

Marium Husain is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Surgery. According to data from OpenAlex, Marium Husain has authored 34 papers receiving a total of 300 indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Oncology, 7 papers in Pulmonary and Respiratory Medicine and 5 papers in Surgery. Recurrent topics in Marium Husain's work include Cancer Immunotherapy and Biomarkers (15 papers), Sarcoma Diagnosis and Treatment (5 papers) and Colorectal Cancer Treatments and Studies (4 papers). Marium Husain is often cited by papers focused on Cancer Immunotherapy and Biomarkers (15 papers), Sarcoma Diagnosis and Treatment (5 papers) and Colorectal Cancer Treatments and Studies (4 papers). Marium Husain collaborates with scholars based in United States and Lebanon. Marium Husain's co-authors include Gregory A. Otterson, Dwight H. Owen, Carolyn J. Presley, Kari Kendra, Mingjia Li, Daniel Spakowicz, Jarred Burkart, David P. Carbone, Claire F. Verschraegen and Erin M. Bertino and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Journal of the American Society of Nephrology.

In The Last Decade

Marium Husain

31 papers receiving 296 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Marium Husain United States 8 224 83 46 40 35 34 300
Amelia Sawyers United States 5 259 1.2× 66 0.8× 45 1.0× 49 1.2× 27 0.8× 8 316
Madison Grogan United States 10 190 0.8× 65 0.8× 33 0.7× 20 0.5× 23 0.7× 30 268
Vilma Pacheco-Barcía Spain 9 345 1.5× 118 1.4× 42 0.9× 58 1.4× 69 2.0× 29 438
Chet Bohac United States 10 223 1.0× 109 1.3× 54 1.2× 86 2.1× 16 0.5× 21 340
Johan Kurnianda Indonesia 10 176 0.8× 86 1.0× 57 1.2× 18 0.5× 48 1.4× 47 314
Valeria Stati Italy 11 182 0.8× 99 1.2× 61 1.3× 27 0.7× 43 1.2× 25 319
Maxime Frélaut France 9 290 1.3× 119 1.4× 34 0.7× 44 1.1× 36 1.0× 23 404
Capucine Baldini France 10 184 0.8× 96 1.2× 36 0.8× 12 0.3× 46 1.3× 19 336
Rebecca Herbertson United Kingdom 8 153 0.7× 78 0.9× 48 1.0× 25 0.6× 33 0.9× 18 295
D. Lefeuvre France 9 257 1.1× 53 0.6× 43 0.9× 147 3.7× 48 1.4× 20 437

Countries citing papers authored by Marium Husain

Since Specialization
Citations

This map shows the geographic impact of Marium Husain's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marium Husain with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marium Husain more than expected).

Fields of papers citing papers by Marium Husain

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marium Husain. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marium Husain. The network helps show where Marium Husain may publish in the future.

Co-authorship network of co-authors of Marium Husain

This figure shows the co-authorship network connecting the top 25 collaborators of Marium Husain. A scholar is included among the top collaborators of Marium Husain based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marium Husain. Marium Husain is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Husain, Marium, et al.. (2023). Case report: The power of immunotherapy in advanced cutaneous squamous cell carcinoma. Frontiers in Oncology. 12. 1081118–1081118. 3 indexed citations
3.
Husain, Marium, Dionisia Quiroga, Menglin Xu, et al.. (2023). Clinical markers of immunotherapy outcomes in advanced sarcoma. BMC Cancer. 23(1). 326–326. 4 indexed citations
4.
Sater, Zahi Abdul, et al.. (2023). The state of cancer research in fragile and conflict-affected settings in the Middle East and North Africa Region: A bibliometric analysis. Frontiers in Oncology. 13. 1083836–1083836. 5 indexed citations
5.
Kwon, Hyunwoo, et al.. (2023). Sorafenib-Induced Capillary Leak Syndrome. SHILAP Revista de lepidopterología. 16(1). 1087–1094.
6.
Husain, Marium, Muhammad Salman Faisal, Dionisia Quiroga, et al.. (2023). A cancer disparities curriculum in a hematology/oncology fellowship program. BMC Medical Education. 23(1). 773–773. 2 indexed citations
7.
Tinoco, Gabriel, David A. Liebner, David J. Konieczkowski, et al.. (2023). Dendritic/histiocytic cell sarcoma: The OSU experience.. Journal of Clinical Oncology. 41(16_suppl). e23552–e23552.
8.
Husain, Marium, Rebecca Hoyd, Alexa Meara, et al.. (2023). De-correlating immune checkpoint inhibitor toxicity and response in melanoma via the microbiome.. Journal of Clinical Oncology. 41(16_suppl). 9569–9569. 2 indexed citations
9.
Rublee, Caitlin, et al.. (2023). Climate mitigation and adaptation is cancer prevention and control. SHILAP Revista de lepidopterología. 10. 100209–100209. 6 indexed citations
10.
Johns, Andrew, Lai Wei, Madison Grogan, et al.. (2023). Risk Factors for Immune Checkpoint Inhibitor Immunotherapy Toxicity Among Older Adults with Cancer. The Oncologist. 28(8). e625–e632. 7 indexed citations
11.
Husain, Marium, Luxi Chen, David A. Liebner, et al.. (2023). Emerging Trends in Immunotherapy for Adult Sarcomas. The Oncologist. 28(5). e233–e241. 2 indexed citations
12.
Johns, Andrew, Lai Wei, Madison Grogan, et al.. (2023). Association of medical comorbidities and cardiovascular disease with toxicity and survival among patients receiving checkpoint inhibitor immunotherapy. Cancer Immunology Immunotherapy. 72(7). 2005–2013. 7 indexed citations
13.
Tinoco, Gabriel, Songzhu Zhao, Lai Wei, et al.. (2022). Immune checkpoint inhibitor-induced hepatitis injury: risk factors, outcomes, and impact on survival. Journal of Cancer Research and Clinical Oncology. 149(5). 2235–2242. 25 indexed citations
14.
Johns, Andrew, Lai Wei, Madison Grogan, et al.. (2021). Checkpoint inhibitor immunotherapy toxicity and overall survival among older adults with advanced cancer. Journal of Geriatric Oncology. 12(5). 813–819. 27 indexed citations
15.
Husain, Marium, Menglin Xu, Sandipkumar Patel, et al.. (2021). Proton pump inhibitor use (PPI) in patients treated with immune checkpoint inhibitors (ICI) for advanced cancer: Survival and prior therapy.. Journal of Clinical Oncology. 39(15_suppl). 2633–2633. 9 indexed citations
16.
Li, Mingjia, Daniel Spakowicz, Songzhu Zhao, et al.. (2020). Brief report: inhaled corticosteroid use and the risk of checkpoint inhibitor pneumonitis in patients with advanced cancer. Cancer Immunology Immunotherapy. 69(11). 2403–2408. 12 indexed citations
17.
Prosek, Jason, Dwight H. Owen, Marium Husain, et al.. (2020). Statin Use, Renal Cell Carcinoma, and Combination Immunotherapy Increase Risk of Checkpoint Inhibitor-Induced Nephritis: A Single-Center Database Study. Journal of the American Society of Nephrology. 31(10S). 663–663. 1 indexed citations
18.
Li, Mingjia, Daniel Spakowicz, Jarred Burkart, et al.. (2019). Change in neutrophil to lymphocyte ratio during immunotherapy treatment is a non-linear predictor of patient outcomes in advanced cancers. Journal of Cancer Research and Clinical Oncology. 145(10). 2541–2546. 82 indexed citations
19.
Spakowicz, Daniel, Marium Husain, Gabriel Tinoco, et al.. (2019). Effect of concomitant medications on overall survival in patients with cancer undergoing immunotherapy.. Journal of Clinical Oncology. 37(8_suppl). 94–94. 4 indexed citations
20.
Husain, Marium, Amber Hartman, & Payal Desai. (2017). Pharmacogenomics of sickle cell disease: steps toward personalized medicine. Pharmacogenomics and Personalized Medicine. Volume 10. 261–265. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Amelia Sawyers Breakdown of academic impact, for papers by Madison Grogan Breakdown of academic impact, for papers by Vilma Pacheco-Barcía Breakdown of academic impact, for papers by Chet Bohac Breakdown of academic impact, for papers by Johan Kurnianda Breakdown of academic impact, for papers by Valeria Stati Breakdown of academic impact, for papers by Maxime Frélaut Breakdown of academic impact, for papers by Capucine Baldini Breakdown of academic impact, for papers by Rebecca Herbertson Breakdown of academic impact, for papers by D. Lefeuvre
Rankless by CCL
2026